
North America Digital Therapeutics Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Application [Diabetes, Cardiovascular Diseases, Central Nervous System (CNS) Disease, Respiratory Diseases, Smoking Cessation, Musculoskeletal Diseases,
Description
North America Digital Therapeutics Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Application [Diabetes, Cardiovascular Diseases, Central Nervous System (CNS) Disease, Respiratory Diseases, Smoking Cessation, Musculoskeletal Diseases, and Others] and Distribution Channel (Patients, Providers, Payers, and Employers)
The North America digital therapeutics market is expected to reach US$ 7,323.29 million by 2028 from US$ 1,740.46 million in 2021; it is estimated to grow at a CAGR of 22.8% from 2021 to 2028.
The growth of the market is attributed to the rising prevalence of chronic diseases and growing need to reduce the cost of healthcare. However, cyber threat and risk related to data security restrict the market growth.
Chronic diseases, such as heart disease, stroke, diabetes, and obesity, account for most of the healthcare costs of any country. According to a report by the World Health Organization (WHO), 463 million adults in the world had diabetes in 2020, and the number is expected to rise to 629 million by 2045. Moreover, as per the Centers for Disease Control and Prevention (CDC) data published in 2018, 1.4 million Americans are diagnosed with diabetes every year in the US. According to the IDF Diabetes Atlas 2021, published by the International Diabetes Federation, North America reported ~51 million people affected by diabetes in 2021, and the number is expected to reach 63 million by 2045. As per a report by the American College of Cardiology Foundation, coronary heart disease (CHD) was a leading cause of death in the US in 2018, attributable to cardiovascular disease (CVD), followed by stroke (16.8%), high BP (9.4%), heart failure (9.0%), and other CVDs (17.9%). By 2035, ~130 million adults in the US population are projected to suffer from some form of CVDs.
The obesity rates are increasing rapidly in developed and developing economies in North America due to sedentary and unhealthy lifestyles. As per data published by the Organization for Economic Co-operation (OECD) in 2017, ~19.5% of the adult population was obese in OECD area. This rate is less than 6% in Korea and Japan, and more than 30% in Hungary, New Zealand, Mexico, and the US. Obesity levels are anticipated to reach ~47%, ~39%, and ~35% in the US, Mexico, and England, respectively, by 2030.
To enhance chronic disease management and offer various treatment options to patients, digital therapeutics help deliver evidence-based therapeutic solutions. It enable patients to better control their care and provides potential solutions for chronic diseases management, such as diabetes. Hence, the rise in the prevalence of chronic diseases is driving the digital therapeutics market growth.
North America Digital Therapeutics Market Revenue and Forecast to 2028 (US$ Million)
North America Digital Therapeutics Market Segmentation
By Application
Diabetes Cardiovascular Diseases Central Nervous System (CNS) Disease Respiratory Smoking Cessation Musculoskeletal Diseases Others By End User
Patients Providers Payers Employers By Country
â¢USâ¢Canadaâ¢Mexico Company Profiles
â¢Propeller Health (Res Med)â¢Canary Healthâ¢Noom, Incâ¢2Morrow, Inc.â¢Teladoc Health, Inc.â¢Welldoc, Inc.â¢Fitbit, Inc.â¢Omada Health, Inc.â¢MANGO HEALTHâ¢Pear Therapeutics, Inc.
Reasons to Buy
Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the North America digital therapeutics market.
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in the North America digital therapeutics market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth market trends and outlook coupled with the factors driving the market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
The North America digital therapeutics market is expected to reach US$ 7,323.29 million by 2028 from US$ 1,740.46 million in 2021; it is estimated to grow at a CAGR of 22.8% from 2021 to 2028.
The growth of the market is attributed to the rising prevalence of chronic diseases and growing need to reduce the cost of healthcare. However, cyber threat and risk related to data security restrict the market growth.
Chronic diseases, such as heart disease, stroke, diabetes, and obesity, account for most of the healthcare costs of any country. According to a report by the World Health Organization (WHO), 463 million adults in the world had diabetes in 2020, and the number is expected to rise to 629 million by 2045. Moreover, as per the Centers for Disease Control and Prevention (CDC) data published in 2018, 1.4 million Americans are diagnosed with diabetes every year in the US. According to the IDF Diabetes Atlas 2021, published by the International Diabetes Federation, North America reported ~51 million people affected by diabetes in 2021, and the number is expected to reach 63 million by 2045. As per a report by the American College of Cardiology Foundation, coronary heart disease (CHD) was a leading cause of death in the US in 2018, attributable to cardiovascular disease (CVD), followed by stroke (16.8%), high BP (9.4%), heart failure (9.0%), and other CVDs (17.9%). By 2035, ~130 million adults in the US population are projected to suffer from some form of CVDs.
The obesity rates are increasing rapidly in developed and developing economies in North America due to sedentary and unhealthy lifestyles. As per data published by the Organization for Economic Co-operation (OECD) in 2017, ~19.5% of the adult population was obese in OECD area. This rate is less than 6% in Korea and Japan, and more than 30% in Hungary, New Zealand, Mexico, and the US. Obesity levels are anticipated to reach ~47%, ~39%, and ~35% in the US, Mexico, and England, respectively, by 2030.
To enhance chronic disease management and offer various treatment options to patients, digital therapeutics help deliver evidence-based therapeutic solutions. It enable patients to better control their care and provides potential solutions for chronic diseases management, such as diabetes. Hence, the rise in the prevalence of chronic diseases is driving the digital therapeutics market growth.
North America Digital Therapeutics Market Revenue and Forecast to 2028 (US$ Million)
North America Digital Therapeutics Market Segmentation
By Application
Diabetes Cardiovascular Diseases Central Nervous System (CNS) Disease Respiratory Smoking Cessation Musculoskeletal Diseases Others By End User
Patients Providers Payers Employers By Country
â¢USâ¢Canadaâ¢Mexico Company Profiles
â¢Propeller Health (Res Med)â¢Canary Healthâ¢Noom, Incâ¢2Morrow, Inc.â¢Teladoc Health, Inc.â¢Welldoc, Inc.â¢Fitbit, Inc.â¢Omada Health, Inc.â¢MANGO HEALTHâ¢Pear Therapeutics, Inc.
Reasons to Buy
Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the North America digital therapeutics market.
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in the North America digital therapeutics market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth market trends and outlook coupled with the factors driving the market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
Table of Contents
127 Pages
- 1. Introduction
- 1.1 Scope of the Study
- 1.2 The Insight Partners Research Report Guidance
- 1.3 Market Segmentation
- 1.3.1 Digital Therapeutics Market– By Application
- 1.3.2 Digital Therapeutics Market– By Distribution Channel
- 1.3.3 Digital Therapeutics Market– By Country
- 2. Digital Therapeutics Market– Key Takeaways
- 3. Research Methodology
- 3.1 Coverage
- 3.2 Secondary Research
- 3.3 Primary Research
- 4. North America Digital Therapeutics Market– Market Landscape
- 4.1 Overview
- 4.2 PEST Analysis
- 4.2.1 North America: PEST Analysis
- 4.3 Expert Opinion
- 5. Digital Therapeutics Market– Key Market Dynamics
- 5.1 Market Drivers
- 5.1.1 Rising Prevalence of Chronic Diseases
- 5.1.2 Concerns Regarding Need to Reduce Healthcare Costs
- 5.1.3 Partnerships and Collaborations by Companies
- 5.2 Market Restraints
- 5.2.1 Cyber Threat and Rise in Data Security
- 5.3 Market Opportunities
- 5.3.1 Large Population with Undiagnosed Conditions
- 5.4 Future Trends
- 5.4.1 Increasing Number of Start-Ups
- 5.5 Impact analysis
- 6. North America Digital Therapeutics Market Analysis
- 6.1 North America Digital Therapeutics Market Revenue Forecast and Analysis
- 7. Digital Therapeutics Market Analysis – By Application
- 7.1 Overview
- 7.2 Digital Therapeutics Market Revenue Share, by Application (2021 and 2028)
- 7.3 Diabetes
- 7.3.1 Overview
- 7.3.2 Diabetes: Digital Therapeutics Market Revenue and Forecasts to 2028 (US$ Million)
- 7.3.3 Cardiovascular Disease
- 7.3.3.1 Overview
- 7.3.3.2 Cardiovascular Disease: Digital Therapeutics Market Revenue and Forecasts to 2028 (US$ Million)
- 7.3.4 Central Nervous System Diseases
- 7.3.4.1 Overview
- 7.3.4.2 Central Nervous System Diseases: Digital Therapeutics Market Revenue and Forecasts to 2028 (US$ Million)
- 7.3.5 Respiratory Diseases
- 7.3.5.1 Overview
- 7.3.5.2 Respiratory Diseases: Digital Therapeutics Market Revenue and Forecasts to 2028 (US$ Million)
- 7.3.6 Smoking Cessation
- 7.3.6.1 Overview
- 7.3.6.2 Smoking Cessation: Digital Therapeutics Market Revenue and Forecasts to 2028 (US$ Million)
- 7.3.7 Musculoskeletal Disorders
- 7.3.7.1 Overview
- 7.3.7.2 Musculoskeletal Disorders: Digital Therapeutics Market Revenue and Forecasts to 2028 (US$ Million)
- 7.3.8 Others
- 7.3.8.1 Overview
- 7.3.8.2 Others: Digital Therapeutics Market Revenue and Forecasts to 2028 (US$ Million)
- 8. Digital Therapeutics Market Analysis – By Distribution Channel
- 8.1 Overview
- 8.2 Digital Therapeutics Market Revenue Share, by Distribution Channel (2021 and 2028)
- 8.3 Patients
- 8.3.1 Overview
- 8.3.2 Patients: Digital Therapeutics Market– Revenue and Forecast to 2028 (US$ Million)
- 8.4 Providers
- 8.4.1 Overview
- 8.4.2 Providers: Digital Therapeutics Market– Revenue and Forecast to 2028 (US$ Million)
- 8.5 Payers
- 8.5.1 Overview
- 8.5.2 Payers: Digital Therapeutics Market– Revenue and Forecast to 2028 (US$ Million)
- 8.6 Employers
- 8.6.1 Overview
- 8.6.2 Employers: Digital Therapeutics Market– Revenue and Forecast to 2028 (US$ Million)
- 9. Digital Therapeutics Market–Country Analysis
- 9.1 North America: Digital Therapeutics Market
- 9.1.1 Overview
- 9.1.2 North America: Digital Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)
- 9.1.3 North America: Digital Therapeutics Market, by Application, 2019–2028 (US$ Million)
- 9.1.4 North America: Digital Therapeutics Market, by Distribution Channel, 2019–2028 (US$ Million)
- 9.1.5 North America: Digital Therapeutics Market, by Country, 2021 & 2028 (%)
- 9.1.5.1 US: Digital Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)
- 9.1.5.1.1 Overview
- 9.1.5.1.2 US: Digital Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)
- 9.1.5.1.3 US: Digital Therapeutics Market, by Application, 2019–2028 (US$ Million)
- 9.1.5.1.4 US: Digital Therapeutics Market, by Distribution Channel, 2019–2028 (US$ Million)
- 9.1.5.2 Canada: Digital Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)
- 9.1.5.2.1 Overview
- 9.1.5.2.2 Canada: Digital Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)
- 9.1.5.2.3 anada: Digital Therapeutics Market, by Application, 2019–2028 (US$ Million)
- 9.1.5.2.4 Canada: Digital Therapeutics Market, by Distribution Channel, 2019–2028 (US$ Million)
- 9.1.5.3 Mexico: Digital Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)
- 9.1.5.3.1 Overview
- 9.1.5.3.2 Mexico: Digital Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)
- 9.1.5.3.3 Mexico: Digital Therapeutics Market, by Application, 2019–2028 (US$ Million)
- 9.1.5.3.4 Mexico: Digital Therapeutics Market, by Distribution Channel, 2019–2028 (US$ Million)
- 10. Impact of COVID-19 Pandemic on North America Digital Therapeutics Market
- 10.1 North America: Impact Assessment of COVID-19 Pandemic
- 11. Digital Therapeutics Market –Industry Landscape
- 11.1 Overview
- 11.2 Inorganic Growth Strategies
- 11.2.1 Overview
- 11.3 Organic Growth Strategies
- 11.3.1 Overview
- 12. Company Profiles
- 12.1 Propeller Health (ResMed)
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
- 12.2 Canary Health
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
- 12.3 Noom, Inc.
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
- 12.4 2Morrow, Inc.
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
- 12.5 Teladoc Health, Inc.
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
- 12.6 Welldoc, Inc.
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
- 12.7 Fitbit, Inc.
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
- 12.8 Omada Health, Inc.
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
- 12.9 MANGO HEALTH
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments
- 12.10 Pear Therapeutics, Inc.
- 12.10.1 Key Facts
- 12.10.2 Business Description
- 12.10.3 Products and Services
- 12.10.4 Financial Overview
- 12.10.5 SWOT Analysis
- 12.10.6 Key Developments
- 12.11 Happify Health
- 12.11.1 Key Facts
- 12.11.2 Business Description
- 12.11.3 Products and Services
- 12.11.4 Financial Overview
- 12.11.5 SWOT Analysis
- 12.11.6 Key Developments
- 13. Appendix
- 13.1 About the Insight Partners
- 13.2 Glossary of Terms
- List of Tables
- Table 1. Proportion Of People Living With Undiagnosed Diabetes (20–79 years) Per Region, 2021
- Table 2. North America Digital Therapeutics Market, by Application – Revenue and Forecast to 2028 (US$ Million)
- Table 3. North America Digital Therapeutics Market, by Distribution Channel– Revenue and Forecast to 2028 (USD Million)
- Table 4. US Digital Therapeutics Market, by Application – Revenue and Forecast to 2028 (US$ Million)
- Table 5. US Digital Therapeutics Market, by Distribution Channel– Revenue and Forecast to 2028 (US$ Million)
- Table 6. Canada: Digital Therapeutics Market, by Application – Revenue and Forecast to 2028 (US$ Million)
- Table 7. Canada Digital Therapeutics Market, by Distribution Channel– Revenue and Forecast to 2028 (US$ Million)
- Table 8. Mexico: Digital Therapeutics Market, by Application – Revenue and Forecast to 2028 (US$ Million)
- Table 9. Mexico Digital Therapeutics Market, by Distribution Channel– Revenue and Forecast to 2028 (US$ Million)
- Table 10. Recent Inorganic Growth Strategies in the Digital Therapeutics Market
- Table 11. Recent Organic Growth Strategies in the Digital Therapeutics Market
- Table 12. Glossary of Terms, Digital Therapeutics Market
- List of Figures
- Figure 1. Digital Therapeutics Market Segmentation
- Figure 2. Digital Therapeutics Market– By Country
- Figure 3. Digital Therapeutics Market Overview
- Figure 4. Diabetes Segment Held Largest Share of Digital Therapeutics Market by Application
- Figure 5. North America Digital Therapeutics Market– Leading Country Markets (US$ Million)
- Figure 6. North America: PEST Analysis
- Figure 7. Expert Opinion
- Figure 8. Digital Therapeutics market impact analysis of driver and restraints
- Figure 9. North America Digital Therapeutics Market – Revenue Forecast and Analysis – 2021 - 2028
- Figure 10. Digital Therapeutics Market Revenue Share, by Application (2021 and 2028)
- Figure 11. Diabetes: Digital Therapeutics Market Revenue and Forecasts to 2028 (US$ Million)
- Figure 12. Cardiovascular Disease: Digital Therapeutics Market Revenue and Forecasts to 2028 (US$ Million)
- Figure 13. Central Nervous System Diseases: Digital Therapeutics Market Revenue and Forecasts to 2028 (US$ Million)
- Figure 14. Respiratory Diseases: Digital Therapeutics Market Revenue and Forecasts to 2028 (US$ Million)
- Figure 15. Smoking Cessation: Digital Therapeutics Market Revenue and Forecasts to 2028 (US$ Million)
- Figure 16. Musculoskeletal Disorders: Digital Therapeutics Market Revenue and Forecasts to 2028 (US$ Million)
- Figure 17. Others: Digital Therapeutics Market Revenue and Forecasts to 2028 (US$ Million)
- Figure 18. Digital Therapeutics Market Revenue Share, by Distribution Channel (2021 and 2028)
- Figure 19. Patients: Digital Therapeutics Market– Revenue and Forecast to 2028 (US$ Million)
- Figure 20. Providers: Digital Therapeutics Market– Revenue and Forecast to 2028 (US$ Million)
- Figure 21. Payers: Digital Therapeutics Market– Revenue and Forecast to 2028 (US$ Million)
- Figure 22. Employers: Digital Therapeutics Market– Revenue and Forecast to 2028 (US$ Million)
- Figure 23. North America: Digital Therapeutics Market, by Key Country – Revenue (2021) (US$ Million)
- Figure 24. North America Digital Therapeutics Market Revenue and Forecast to 2028 (US$ Million)
- Figure 25. North America: Digital Therapeutics Market, by Country, 2021 & 2028 (%)
- Figure 26. US: Digital Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)
- Figure 27. Canada: Digital Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)
- Figure 28. Mexico: Digital Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)
- Figure 29. Impact of COVID-19 Pandemic in North American Country Markets
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.